Sildenafil Citrate Market Size

  • Report ID: 2582
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Sildenafil Citrate Market Size

Sildenafil Citrate Market size was valued at USD 1.58 billion in 2023 and is expected to reach USD 3.13 billion by 2036, expanding at around 5.4% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of sildenafil citrate is assessed at USD 1.65 billion.

The increase in erectile dysfunction cases on account of the rising cases related to heart diseases, diabetes, obesity, blood pressure, tobacco and alcohol consumption, depression, stress, food habits along with an ageing population are estimated to contribute to the market growth. Based on its use, the market is bifurcated into medical and non-medical usage, out of which, the largest share in the market is estimated to be held by medical segment in order to treat erectile dysfunction in men. This can be attributed to its low cost in the market and the requirement of a prescription by medical professionals. The market is further segmented by distributed channel into online and offline distribution channels. Among these segments, the offline segment is anticipated to continue holding the leading share in the market since it was the highest revenue generating segment in 2019 owing to the rising availability of the product. Additionally, the high product awareness is driving also contributed to the growth of the segment. 


Global-Sildenafil-Citrate-Market
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 2582
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of sildenafil citrate is assessed at USD 1.65 billion.

Sildenafil Citrate Market size was valued at USD 1.58 billion in 2023 and is expected to reach USD 3.13 billion by 2036, expanding at around 5.4% CAGR during the forecast period i.e., between 2024-2036.

North America industry is predicted to hold largest revenue share by 2036, propelled by higher number of ED cases in the region.

The major players in the market are Pfizer Inc., Bayer AG, Apricus Biosciences, Inc., Cristália, Aglowmed Pharmaceuticals Ltd., Mylan N.V., VIVUS Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample